Viatris Gross Margin 2010-2024 | VTRS

Current and historical gross margin for Viatris (VTRS) over the last 10 years. The current gross profit margin for Viatris as of June 30, 2024 is %.
Viatris Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-06-30 $15.24B $6.24B 40.93%
2024-03-31 $15.36B $6.40B 41.67%
2023-12-31 $15.43B $6.44B 41.74%
2023-09-30 $15.47B $6.12B 39.54%
2023-06-30 $15.60B $6.17B 39.57%
2023-03-31 $15.80B $6.27B 39.66%
2022-12-31 $16.26B $6.50B 39.94%
2022-09-30 $16.73B $6.77B 40.46%
2022-06-30 $17.19B $6.59B 38.36%
2022-03-31 $17.65B $6.22B 35.24%
2021-12-31 $17.89B $5.58B 31.17%
2021-09-30 $17.17B $4.74B 27.58%
2021-06-30 $15.60B $4.32B 27.69%
2021-03-31 $13.76B $4.02B 29.21%
2020-12-31 $11.95B $3.80B 31.78%
2020-09-30 $11.51B $4.18B 36.29%
2020-06-30 $11.50B $4.09B 35.56%
2020-03-31 $11.63B $4.00B 34.39%
2019-12-31 $11.50B $3.90B 33.88%
2019-09-30 $11.39B $3.83B 33.59%
2019-06-30 $11.29B $3.79B 33.60%
2019-03-31 $11.25B $3.82B 34.00%
2018-12-31 $11.43B $4.00B 35.00%
2018-09-30 $11.59B $4.28B 36.92%
2018-06-30 $11.72B $4.42B 37.72%
2018-03-31 $11.87B $4.68B 39.43%
2017-12-31 $11.91B $4.78B 40.17%
2017-09-30 $11.94B $4.82B 40.40%
2017-06-30 $12.01B $4.93B 41.04%
2017-03-31 $11.61B $4.88B 42.00%
2016-12-31 $11.08B $4.70B 42.40%
2016-09-30 $10.30B $4.43B 42.96%
2016-06-30 $9.94B $4.46B 44.85%
2016-03-31 $9.75B $4.29B 44.04%
2015-12-31 $9.43B $4.22B 44.71%
2015-09-30 $9.02B $4.12B 45.69%
2015-06-30 $8.41B $3.82B 45.40%
2015-03-31 $7.88B $3.62B 45.96%
2014-12-31 $7.72B $3.53B 45.70%
2014-09-30 $7.45B $3.36B 45.06%
2014-06-30 $7.13B $3.15B 44.21%
2014-03-31 $6.99B $3.09B 44.11%
2013-12-31 $6.91B $3.04B 44.01%
2013-09-30 $6.82B $2.99B 43.77%
2013-06-30 $6.86B $2.97B 43.32%
2013-03-31 $6.85B $2.93B 42.83%
2012-12-31 $6.80B $2.91B 42.78%
2012-09-30 $6.61B $2.81B 42.56%
2012-06-30 $6.38B $2.68B 41.95%
2012-03-31 $6.27B $2.64B 42.17%
2011-12-31 $6.13B $2.56B 41.81%
2011-09-30 $6.03B $2.50B 41.39%
2011-06-30 $5.81B $2.42B 41.62%
2011-03-31 $5.61B $2.29B 40.88%
2010-12-31 $5.45B $2.22B 40.68%
2010-09-30 $5.37B $2.15B 40.13%
2010-06-30 $5.28B $2.08B 39.40%
2010-03-31 $5.18B $2.07B 39.90%
2009-12-31 $5.09B $2.08B 40.74%
Sector Industry Market Cap Revenue
Medical Medical Services $13.858B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00